


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-5.57%
+3.33%
+3.39%
+0.13%
SLXN
Silexion Therapeutics Cor
$0.50

Login to see Silexion Therapeutics Cor (SLXN) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
SLXN Price Performance
$0.64 (-21.88%)
$1.73 (-71.10%)
$1.73 (-71.10%)
$7.26 (-93.11%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Loss widens YoY
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
SLXN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SLXN Street Sentiment is bullish and have negative views on the near-term outlook
SLXN has Low risk level

Sentiments overview associated with events and the stock performance
What is SLXN current stock price?
What is SLXN current Stock IQ?
What is SLXN RSI signal right now?
What is SLXN analyst price target and upside potential?
What do analysts say about SLXN stock?
What is SLXN momentum trend right now?
What are SLXN stock strengths?
What is SLXN Risk Level?
Should I buy SLXN stock right now?
Is SLXN a Strong Buy right now?
What is SLXN market cap and volume?
What factors influence SLXN's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
SLXN
Silexion Therapeutics Cor
Current Price
$0.50

SLXN Price Performance
$0.64 (-21.88%)
$1.73 (-71.10%)
$1.73 (-71.10%)
$7.26 (-93.11%)
SLXN Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Loss widens YoY
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
SLXN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SLXN Street Sentiment is bullish and have negative views on the near-term outlook
SLXN has Low risk level

SLXN Stock IQ
Stock Insights
Not Enough Information
SLXN Trading Signals
SLXN is now at $0.48, down -10.34% from $0.53. This rapid movement warrants attention.
SLXN is showing high volatility with an intraday swing of 18.18% (High: $0.52, Low: $0.44). This signals potential risk.
SLXN has negative earnings news: Loss Widens. Silexion Therapeutics Posts Wider Q1 Loss Advances SIL204 Into Phase 2/3 Trials. Stock Up. (RTTNews) - Silexion Therapeutics Corp. (SLXN) a clinical...
SLXN opened with a gap down of 16.98% (prev close $0.53, open $0.44)
SLXN is trading 123.48% below analyst target price of $1.07, suggesting significant upside potential
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
SLXN Stock trends
SLXN Stock performance
SLXN Stock analysis
SLXN investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.